FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:292-293 July 22, 1999 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Trichomonal resistance to metronidazole was reported soon after its introduction and has been reported in many areas in the world. Although a sexually transmitted disease with dire consequences related to human immunodeficiency virus transmission, trichomoniasis is not a reportable infection, and epidemiologic data on its incidence in the United States are not available. Therefore, it is not surprising that accurate figures on metronidazole-resistant trichomoniasis are almost nonexistent. Nevertheless, clinically important resistance is considered rare, with estimates of high-level resistance to metronidazole occurring in only 1 in 2000 to 3000 cases.¹ In clinics specializing in chronic vaginitis that . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Ali, V., Nozaki, T. (2007). Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by "Amitochondriate" Protozoan Parasites. Clin. Microbiol. Rev. 20: 164-187 [Abstract] [Full Text]  
• Schwebke, J. R., Barrientes, F. J. (2006). Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and Tinidazole. Antimicrob. Agents Chemother. 50: 4209-4210 [Abstract] [Full Text]  
• Blaha, C., Duchene, M., Aspock, H., Walochnik, J. (2006). In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis. J Antimicrob Chemother 57: 273-278 [Abstract] [Full Text]  
• Schwebke, J. R., Burgess, D. (2004). Trichomoniasis. Clin. Microbiol. Rev. 17: 794-803 [Abstract] [Full Text]  
• Coombs, G. H., Westrop, G. D., Suchan, P., Puzova, G., Hirt, R. P., Embley, T. M., Mottram, J. C., Muller, S. (2004). The Amitochondriate Eukaryote Trichomonas vaginalis Contains a Divergent Thioredoxin-linked Peroxiredoxin Antioxidant System. J. Biol. Chem. 279: 5249-5256 [Abstract] [Full Text]  
• Kanno, M, Sobel, J D (2003). Late recurrence of resistant Trichomonas vaginalis vaginitis: relapse or re-infection?. Sex. Transm. Infect. 79: 260-261 [Abstract] [Full Text]  
• Schwebke, J R (2002). Update of trichomoniasis. Sex. Transm. Infect. 78: 378-379 [Abstract] [Full Text]  
• Upcroft, J. A., Upcroft, P. (2001). Drug Susceptibility Testing of Anaerobic Protozoa. Antimicrob. Agents Chemother. 45: 1810-1814 [Abstract] [Full Text]  
• Upcroft, P., Upcroft, J. A. (2001). Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa. Clin. Microbiol. Rev. 14: 150-164 [Abstract] [Full Text]